SiRNA nanotherapeutics: A Trojan horse approach against HIV

Drug Discovery Today

Volumn 19, Issue 12, 2014, Pages 1913-1920

  Mishra, Vijay ^a   Kesharwani, Prashant ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; NANOCARRIER; POLYETHYLENEIMINE; SMALL INTERFERING RNA; DRUG CARRIER; NANOPARTICLE;

CLINICAL TRIAL (TOPIC); CYTOTOXICITY; DRUG MECHANISM; GENE SILENCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; RNA INTERFERENCE; TARGET CELL; VIRUS GENOME; ANIMAL; GENETICS; HIV INFECTIONS; PHYSIOLOGY;

ANIMALS; DRUG CARRIERS; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84919340616     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.09.019     Document Type: Review

References (58)

1. J. Lisziewicz, and E.R. Toke Nanomedicine applications towards the cure of HIV Nanomedicine 9 2013 28 38
2. M.A. Kolber Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution AIDS Rev. 9 2007 68 74
3. A. Fire Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
4. S.M. Elbashir Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
5. G.J. Hannon, and J. Rossi Unlocking the potential of the human genome with RNA interference Nature 431 2004 371 378
6. M.R. Lares RNAi and small interfering RNAs in human disease therapeutic applications Trends Biotechnol. 28 2010 570 579
7. G.J. Hannon RNA interference Nature 418 2002 244 251
8. T.M. Rana Illuminating the silence: under-standing the structure and function of small RNAs Nat. Rev. Mol. Cell Biol. 8 2007 23 36
9. T. Mamo Emerging nanotechnology approaches for HIV/AIDS treatment and prevention Nanomedicine 5 2010 269 285
10. W. Han Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site Virology 330 2004 221 232
11. C. Kuiken HIV Sequence Compendium 2010 2010 Theoretical Biology and Biophysics Group
12. J. Capodici Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference J. Immunol. 169 2002 5196 5201
13. M.A. Martinez Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication AIDS 16 2002 2385 2390
14. C.D. Novina siRNA-directed inhibition of HIV-1 infection Nat. Med. 8 2002 681 686
15. N.S. Lee Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nat. Biotechnol. 20 2002 500 505
16. L. Vandekerckhove RNAi-based treatment of HIV/AIDS: current status and perspectives Drug Discov. Today Ther. Strat. 3 2006 227 235
17. N.S. Lee, and J.J. Rossi Control of HIV-1 replication by RNA interference Virus Res. 102 2004 53 58
18. J.M. Jacque Modulation of HIV-1 replication by RNA interference Nature 418 2002 435 438
19. W. Hu Inhibition of retroviral pathogenesis by RNA interference Curr. Biol. 12 2002 1301 1311
20. R.M. Surabhi, and R.B. Gaynor RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication J. Virol. 76 2002 12963 12973
21. W.S. Park Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference Nucleic Acids Res. 30 2002 4830 4835
22. A.T. Das Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition J. Virol. 78 2004 2601 2605
23. D.S. Strayer Current status of gene therapy strategies to treat HIV/AIDS Mol. Ther. 11 2005 823 842
24. M.A. Martinez Progress in the therapeutic applications of siRNAs against HIV-1 Methods Mol. Biol. 487 2009 343 368
25. C.P. Paul Effective expression of small interfering RNA in human cells Nat. Biotechnol. 20 2002 505 508
26. C.E. Thomas Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4 2003 346 358
27. Y. Zeng, and B.R. Cullen RNA interference in human cells is restricted to the cytoplasm RNA 8 2002 855 860
28. M. Sioud, and D.R. Sorensen Cationic liposome-mediated delivery of siRNAs in adult mice Biochem. Biophys. Res. Commun. 312 2003 1220 1225
29. P. Kesharwani A review of nanocarriers for the delivery of small interfering RNA Biomaterials 33 2012 7138 7150
30. C. Lavigne Influence of lipoplex surface charge on siRNA delivery: application to the in vitro down regulation of CXCR4 HIV-1 co-receptor Exp. Opin. Biol. Ther. 13 2013 973 985
31. E. Song Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23 2005 709 717
32. J.L. Reynolds Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages J. Neuroimmune Pharmacol. 7 2012 673 685
33. J. Zhou Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice Mol. Ther. 19 2011 2228 2238
34. S.K. Eszterhas Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants Infect. Dis. Rep. 3 2011 e11
35. V. Mishra Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes Pharmazie 65 2010 891 895
36. V. Mishra, and N.K. Jain Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits Int. J. Pharm. 461 2014 380 390
37. P. Kesharwani Dendrimer as nanocarrier for drug delivery Prog. Polym. Sci. 39 2014 268 307
38. D.A. Tomalia A new class of polymers: starburst-dendritic macromolecules Polym. J. 17 1985 117 132
39. V. Mishra Surface-engineered dendrimers: a solution for toxicity issues J. Biomater. Sci. 20 2009 141 166
40. P. Kesharwani Evaluation of dendrimer safety and efficacy through cell line studies Curr. Drug Targets 12 2011 1478 1497
41. C. Dufes Dendrimers in gene delivery Adv. Drug Deliv. Rev. 57 2005 2177 2202
42. H. Zhao Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA FEBS Lett. 563 2004 241 245
43. N. Weber Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes J. Control. Release 132 2008 55 64
44. J.F. Bermejo Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications Chemistry 13 2007 483 495
45. A.J. Perisé-Barrios Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection J. Control. Release 184 2014 51 57
46. E. Pedziwiatr-Werbicka Characterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotides Colloids Surf. B 83 2011 360 366
47. L. Chonco Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins Org. Biomol. Chem. 5 2007 1886 1893
48. R. Duncan, and L. Izzo Dendrimer biocompatibility and toxicity Adv. Drug Deliv. Rev. 57 2005 2215 2237
49. L.A. Tziveleka Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents J. Control. Release 117 2007 137 146
50. J. Behr The proton sponge: a trick to enter cells the viruses did not exploit CHIMIA Int. J. Chem. 51 1997 34 36
51. N.D. Weber PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro J. Control. Release 157 2012 55 63
52. J. Zhou Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells Nucleic Acids Res. 37 2009 3094 3109
53. J. Zhou Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy Mol. Ther. 16 2008 1481 1489
54. A. Dove An apt approach Nat. Med. 16 2010 258 260
55. M. Dominska, and D.M. Dykxhoorn Breaking down the barriers: siRNA delivery and endosome escape J. Cell Sci. 123 2010 1183 1189
56. S.H. Kim Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis Biomaterials 29 2008 4439 4446
57. H.J. Kim Highly effective and slow-biodegradable network-type cationic gene delivery polymer: small library-like approach synthesis and characterization Biomaterials 27 2006 2292 2301
58. D.H. Kim Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase Nat. Biotechnol. 22 2004 321 325